Skip to content
No results
  • Home
  • About Us
  • Shop
    • Chinese innovative drug
    • Tablets
    • Capsules
    • Injection
    • oral solution
    • Cream/Gel/Ointment
    • ophthalmic preparations
    • Nasal preparations
    • Inhalation preparation
    • Implant
    • Chinese Medicine
  • Blog
  • Contact Us
Xpharma China
  • Home
  • About Us
  • Shop
    • Chinese innovative drug
    • Tablets
    • Capsules
    • Injection
    • oral solution
    • Cream/Gel/Ointment
    • ophthalmic preparations
    • Nasal preparations
    • Inhalation preparation
    • Implant
    • Chinese Medicine
  • Blog
  • Contact Us
Xpharma China
Suyuan (Trifluridine and Tipiracil Hydrochloride Tablets)
  • Drug news

How much does Suyuan (Trifluridine and Tipiracil Hydrochloride Tablets) Cost& price without insurance in China?

Livtencity (Maribavir Tablets)
  • Drug news

How much does Livtencity (Maribavir Tablets) Cost& price without insurance in China?

Delstrigo (Doravirine, Lamivudine and Tenofovir Disoproxil Fumarate Tablets)
  • Drug news

How much does Delstrigo (Doravirine, Lamivudine and Tenofovir Disoproxil Fumarate Tablets) Cost& price without insurance in China?

Genvoya (Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Alafenamide Fumarate Tablets)
  • Drug news

How much does Genvoya (Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Alafenamide Fumarate Tablets) Cost& price without insurance in China?

Purini (Pretomanid Tablets)
  • Drug news

How much does Purini (Pretomanid Tablets) Cost& price without insurance in China?

Gracevit (Sitafloxacin Tablets)
  • Drug news

How much does Gracevit (Sitafloxacin Tablets) Cost& price without insurance in China?

Orkedia (Evocalcet Tablets)
  • Drug news

How much does Orkedia (Evocalcet Tablets) Cost& price without insurance in China?

Jiangsu Vcare
  • Approved News

VCARE:Sumecigrel marketing application submitted

  • Approved News

Ionis:Tryngolza®Olezarsen approved for marketing in China

  • Drug development

AstraZeneca:AZD5004 has initiated a Phase III clinical trial

everest medicines
  • Approved News

Everest:LEROCHOL®Lerodalcibep has been formally accepted for review.

MSD
  • Approved News

MSD:KEYTRUDA®Pembrolizumab approved for marketing in China

Prev
1 … 6 7 8 9 10 11 12 … 37
Next
Contact us

WeChat: +86 139 2425 9988
WhatsApp : +852 9100 6363
Email: info@xpharma.com.cn

Rm F2-48, 6/F, No. 47 Guomao Road, Hainan, China

Useful Links
  • Medicines
  • Chinese innovative drug
  • Medicines Approved News
  • Drug Development News
  • Drug News
  • Privacy Policy
Email Newsletter

Subscribe to our newsletter and get 10% off your first purchase

Copyright © {2026} -Xpharma China